Stock Updates

Is this Large Market Cap Stock target price reasonable for Edwards Lifesciences Corp. (NYSE:EW)?

The company in question is, Edwards Lifesciences Corp. (NYSE:EW) currently with a stock price of 106.15 (-0.10% today). The market cap for Edwards Lifesciences Corp. is 22877.78, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for Edwards Lifesciences Corp. is 117.59. Currently Edwards Lifesciences Corp. is trading with a P/E of 45.27, and a forward P/E of 32.44. Average volume for Edwards Lifesciences Corp. is 1650.55 and so far today it is 393137.

Performance in the last year for Edwards Lifesciences Corp. has been 35.60%. For EPS growth, Edwards Lifesciences Corp. has seen a growth of -39.80%, and is looking to grow in the next year to 18.57%. More long term stats show that EPS growth has been 19.70% over the last five years and could be 16.82% for the next five years. Edwards Lifesciences Corp. has seen sales growth quarter over quarter at 18.10%, with EPS growth quarter over quarter at 17.40%. The 20-day simple moving average is 4.75%, with the 200-day simple moving average coming to 18.99%.

Since the IPO date for Edwards Lifesciences Corp. on the 3/27/2000, Edwards Lifesciences Corp. has seen performance year to date to be 34.54%. With Edwards Lifesciences Corp. trading at 106.15, the dividend yield is *TBA, and the EPS is 2.35.

So could Edwards Lifesciences Corp., be undervalued? Well as said before P/E is 45.27. The PEG is 2.69, P/S is 8.8 and the P/B is at 9.85. The P/cash is 24.04, with P/free cash flow at 48.67.

Edwards Lifesciences Corp. ability to deal with debt shows that the current ratio is 4, and the quick ratio is 3.2. This is with long term debt/equity at 0.26, and total debt/equity at 0.26.

In terms of margins, Edwards Lifesciences Corp. has a gross margin of 74.60%, an operating margin of 24.70% and a profit margin of 19.80%.Payout ratio for Edwards Lifesciences Corp. is 0.00%. Return on assets come to 13.40% with return on investment coming to 15.90%.

Insider ownership for Edwards Lifesciences Corp., is at 0.40% and institutional ownership comes to 87.70%. Outstanding shares are at 215.3. While shares float is 210.17. The float short is currently 1.73%, and short ratio is 2.21.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment